MEDIGOLD HEALTH CONSULTANCY LIMITED
Get an alert when MEDIGOLD HEALTH CONSULTANCY LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2027-06-29 (in 1y)
Last filed for 2025-09-30
Confirmation statement due
2027-02-24 (in 9mo)
Last made up 2026-02-10
Watchouts
Cash
£838K
+221.1% vs 2024
Net assets
-£13M
-35.1% vs 2024
Employees
949
-12.3% vs 2024
Profit before tax
-£4M
+51.2% vs 2024
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
5 PSCs ceased in last 24 months
Significant control changed hands — see the Ownership section.
Net assets
4-year trend · vs Health Care median
Accounts
4-year trend · latest reflected 2025-09-30
| Metric | Trend | 2022-03-31 | 2023-09-30 | 2024-09-30 | 2025-09-30 |
|---|---|---|---|---|---|
| Turnover | — | — | £71,278,000 | £66,796,000 | |
| Operating profit | — | — | -£908,000 | £2,587,000 | |
| Profit before tax | — | — | -£7,310,000 | -£3,568,000 | |
| Net profit | — | — | -£7,049,000 | -£3,391,000 | |
| Cash | — | — | £261,000 | £838,000 | |
| Total assets less current liabilities | — | — | £21,458,000 | £28,777,000 | |
| Net assets | — | — | -£9,671,000 | -£13,062,000 | |
| Equity | £2,819,000 | -£8,644,000 | -£9,671,000 | -£13,062,000 | |
| Average employees | — | — | 1,082 | 949 | |
| Wages | — | — | £33,975,000 | £32,670,000 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2022-03-31 | 2023-09-30 | 2024-09-30 | 2025-09-30 |
|---|---|---|---|---|---|
| Operating margin | — | — | -1.3% | 3.9% | |
| Net margin | — | — | -9.9% | -5.1% | |
| Return on capital employed | — | — | -4.2% | 9.0% | |
| Gearing (liabilities / total assets) | — | — | 121.5% | 131.6% | |
| Current ratio | — | — | 0.90x | 1.26x | |
| Interest cover | — | — | -0.14x | 0.42x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- IFRS
- Reporting scope
- Consolidated group
- Auditor
- Saffery LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“At the time of approving the financial statements, and following a significant refinancing agreement, the directors have a reasonable expectation that the group has adequate resources to continue in operational existence for the foreseeable future.”
Group structure
- MEDIGOLD HEALTH CONSULTANCY LIMITED · parent
- Medigold Limited 100%
- Medigold Occupational Health Limited 100%
- Hampton Knight Limited 100%
- Industrial Medical and Safety Services Limited 100%
- Matrix Diagnostics Limited 100%
- Medigold HML Holdings Limited 100%
- Health Management Limited 100%
- Health Management (UK) Limited 100%
- Health Management City Limited 100%
Significant events
- “On 13 January 2026, Health Management (UK) Limited and Health Management City Limited were dissolved.”
- “Subsequent to the year end, the shareholders entered into an agreement for the sale of the Medigold Group. The transaction remained subject to completion at the date the financial statements were authorised for issue. The timing and outcome of the transaction remains uncertain, and an estimate of the financial effect on the group cannot be made at this time.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
10 active · 19 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| GOLDSMITH, Sebastian James | Secretary | 2021-01-26 | — | — |
| EMSLIE, Alasdair John, Dr | Director | 2026-04-15 | Aug 1961 | British |
| GOLDSMITH, Alexander John | Director | 2007-10-01 | Dec 1975 | British |
| GOLSON, Christopher Michael | Director | 2026-04-15 | Mar 1982 | Irish |
| KIRBY, Andrew John | Director | 2024-09-01 | Apr 1964 | British,Irish |
| MILES, Simon Richard Andrew | Director | 2026-04-15 | Oct 1967 | British,Irish |
| NOBLE, Andrew Fraser | Director | 2026-04-15 | Jun 1968 | British |
| SMITH, Richard Graham | Director | 2024-09-01 | Oct 1975 | British |
| SYROTIUK, James Michael | Director | 2024-09-01 | Aug 1985 | British |
| WHITING, Oliver | Director | 2026-04-15 | Apr 1993 | British |
Show 19 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| GOLDSMITH, Amanda Susan | Secretary | 1998-02-10 | 2021-01-26 |
| WING, Clifford Donald | Secretary | 1998-02-10 | 1998-02-10 |
| CAULTON, Eliot Robert Spencer | Director | 2014-12-10 | 2024-08-31 |
| CLARK, Jeanette | Director | 2000-05-22 | 2008-04-30 |
| COLES, Peter Keith Lindsay | Director | 2005-07-01 | 2014-11-01 |
| FOSTER, Genifer Lesley | Director | 2001-05-21 | 2019-09-30 |
| GIBSON, Fiona Jane | Director | 2022-04-21 | 2026-04-15 |
| GOLDSMITH, Amanda Susan | Director | 1998-02-10 | 2024-08-31 |
| GOLDSMITH, Michael John, Dr | Director | 1998-02-10 | 2024-08-31 |
| JACKSON, Mark Bentley | Director | 2017-10-19 | 2024-07-31 |
| LEESER, Andrew John | Director | 2024-08-14 | 2026-04-15 |
| MURPHY, Alan Michael, Dr | Director | 2005-07-01 | 2008-08-01 |
| PACKER, Joanne | Director | 2022-07-01 | 2024-08-31 |
| SMITH, Scot | Director | 2014-11-01 | 2024-01-01 |
| SWAN, Alexander Julian, Dr | Director | 2014-05-01 | 2016-10-28 |
| SYROTIUK, James Michael | Director | 2017-10-19 | 2022-04-21 |
| THOMAS, Viv, Doctor | Director | 1998-03-17 | 2005-06-30 |
| VICKERS, Mark | Director | 2012-04-02 | 2019-02-08 |
| WILLIAMS, John Gareth, Dr | Director | 2013-02-01 | 2022-10-05 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Health Partners Group Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2026-04-15 | Active |
| Mr Sebastian James Goldsmith | Individual | Shares 25–50% | 2021-02-25 | Ceased 2026-04-15 |
| Bgf Gp Limited | Corporate entity | Shares 25–50%, Voting 25–50% | 2017-10-19 | Ceased 2026-04-15 |
| Mr Alexander John Goldsmith | Individual | Shares 25–50% | 2016-04-06 | Ceased 2026-04-15 |
| Mrs Amanda Susan Goldsmith | Individual | Shares 25–50%, Voting 25–50% | 2016-04-06 | Ceased 2026-04-15 |
| Dr Michael John Goldsmith | Individual | Shares 25–50%, Voting 25–50% | 2016-04-06 | Ceased 2026-04-15 |
Filing timeline
Last 20 of 192 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-05-05 | AP01 | officers | Appoint person director company with name date | |
| 2026-04-30 | AP01 | officers | Appoint person director company with name date | |
| 2026-04-24 | AP01 | officers | Appoint person director company with name date | |
| 2026-04-24 | AP01 | officers | Appoint person director company with name date | |
| 2026-04-24 | AP01 | officers | Appoint person director company with name date | |
| 2026-04-24 | TM01 | officers | Termination director company with name termination date | |
| 2026-04-24 | TM01 | officers | Termination director company with name termination date | |
| 2026-04-24 | PSC02 | persons-with-significant-control | Notification of a person with significant control | |
| 2026-04-24 | PSC07 | persons-with-significant-control | Cessation of a person with significant control | |
| 2026-04-24 | PSC07 | persons-with-significant-control | Cessation of a person with significant control | |
| 2026-04-24 | PSC07 | persons-with-significant-control | Cessation of a person with significant control | |
| 2026-04-24 | PSC07 | persons-with-significant-control | Cessation of a person with significant control | |
| 2026-04-24 | PSC07 | persons-with-significant-control | Cessation of a person with significant control | |
| 2026-04-17 | AA | accounts | Accounts with accounts type group | |
| 2026-04-15 | SH01 | capital | Capital allotment shares | |
| 2026-03-28 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2026-03-26 | PSC04 | persons-with-significant-control | Change to a person with significant control | |
| 2026-02-23 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2026-02-10 | SH19 | capital | Capital statement capital company with date currency figure | |
| 2026-02-10 | SH20 | capital | Legacy |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 20
- Capital events
- 3
- Officers appointed
- 5
- Officers resigned
- 2
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2024 → FY2025 · period ending 2025-09-30 vs 2024-09-30
-
Turnover
-6.3%
£71,278,000 £66,796,000
-
Cash
+221.1%
£261,000 £838,000
-
Net assets
-35.1%
-£9,671,000 -£13,062,000
-
Employees
-12.3%
1,082 949
-
Operating profit
+384.9%
-£908,000 £2,587,000
-
Profit before tax
+51.2%
-£7,310,000 -£3,568,000
-
Wages
-3.8%
£33,975,000 £32,670,000
Each % is (latest − prior) ÷ |prior| for the line item as filed. Periods don't have to be exactly 12 months apart — a long or short period (typical around incorporation or year-end changes) will distort the comparison. Lines a company doesn't report are omitted. About these numbers